Inflammation

Latest News

Woman measuring man's waist with tape measure | Image Credit: fotoduets - stock.adobe.com
Higher Weight-Adjusted Waist Index Tied to Greater Mortality Risk in Patients With Osteoarthritis

April 23rd 2025

Researchers consider the weight-adjusted waist index a more precise predictor of mortality risk in patients with osteoarthritis than traditional obesity measures, like body mass index.

"Overactive bladder" written on sticky note | Image Credit: syahrir - stock.adobe.com
Elevated Inflammatory Marker Levels Associated With Increased Overactive Bladder Risk

April 15th 2025

Human brain illustration | Image Credit: Siarhei - stock.adobe.com
Inflammatory Diets Raise Risk of Brain Disorders

April 10th 2025

Guselkumab | Image Credit: luchschenF - stock.adobe.com
Guselkumab Shows Sustained Efficacy in Phase 3b APEX Study for Active PsA

April 8th 2025

COPD graphic | Image Credit: Maks_Lab - stock.adobe.com
Systemic Immune Response Index Identified as Independent Risk Factor for COPD

March 23rd 2025

Continuing Medical Education
View All
April 30th 2025

Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Know

1.5 Credits / Immunology, Allergy
April 30th 2025

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

May 20, 2025 | 1:00 PM and 8:00 PM ET
April 30th 2025

Exploring Innovative Approaches in Myasthenia Gravis and the Specialty Pharmacist’s Role in Optimizing Value-Based Treatment

1.5 Credits / Immunology
April 30th 2025

Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care

1.5 Credits / Dermatology, Immunology
April 30th 2025

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

1.0 Credit / Immunology, Neurology
April 30th 2025

Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

1.0 Credit / Gastroenterology, Immunology, Rare Diseases
April 30th 2025

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory
April 30th 2025

Managed Care Approaches to Individualize Treatment of Hereditary Angioedema

1.0 Credit / Immunology
April 30th 2025

From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

1.5 Credits / Allergy, Immunology

More News

Patient being treated for asthma
October 31st 2022

Urgent Need for CRSwNP Treatment Optimization in Finland

Maggie L. Shaw
A significant uptick in chronic rhinosinusitis with nasal polyps (CRSwNP) among patients with comorbid asthma has been seen in the country over the past decade.
Image of endoscopy
October 27th 2022

Minor Motility Disorders Common in EoE, Says Meta-Analysis

Jaime Rosenberg
The findings follow recent data suggesting that esophageal dysmotility may be associated with eosinophilic esophagitis (EoE), which often presents with dysphagia.
Image of foods that can trigger a reaction
October 26th 2022

Fixed Structural Disease May Predict EoE Response to Elimination Diet

Jaime Rosenberg
The study, say researchers, adds insight into risk factors predictive of response to dietary intervention for eosinophilic esophagitis (EoE), as dietary failure occurs in up to 30% of patients.
Image of an index
October 22nd 2022

New Index Aims to Help Clinicians Gauge Severity of EoE Cases

Jared Kaltwasser
The index for eosinophilic esophagitis (EoE) was crafted based on a literature review by a multidisciplinary team of experts.
Stylized image of disease burden
October 20th 2022

CRSwNP Likely Leads to Greater Overall Disease Burden Following Surgery

Maggie L. Shaw
The goal of this new study was to gain more information on the disease burden, including costs, of patients living with chronic rhinosinusitis with nasal polyps (CRSwNP).
graphic of gastrointestinal system
October 18th 2022

Patients With Asthma, Other Allergic Diseases May Have Higher Prevalence of EoE

Jaime Rosenberg
While the prevalence of eosinophilic esophagitis (EoE) is estimated to be 0.5% in the general population, a recent study found that the prevalence was as high as 16.5% in patients with allergic disease.
Nasal sprays and drops
October 12th 2022

Review Finds Insufficient Evidence Supporting Corticosteroid Irrigation for CRS With Nasal Polyps

Christina Mattina
A search of the peer-reviewed literature turned up inconsistent findings on the effectiveness of corticosteroid irrigation for the treatment of chronic rhinosinusitis (CRS) with nasal polyps.
Person with irritated nose
October 8th 2022

Dupilumab Outcomes Similar in CRSwNP Among Treatment-Naïve, Postsurgical Patients

Maggie L. Shaw
The effect of dupilumab was investigated among patients with severe and uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP).
Image of a person with an irritated nose
October 4th 2022

Periostin as Biomarker May Be More Useful Than Eosinophils in ECRS

Maggie L. Shaw
Despite extensive study, eosinophilic chronic rhinosinusitis (ECRS) remains a significant health problem with few effective treatments, so this study compared periostin levels among those who did and did not have ECRS to assess its potential as a disease biomarker.
Abstract image of a person with asthma
September 30th 2022

Four Factors Identified as Potential Risks for Comorbid CRSwNP, Asthma

Maggie L. Shaw
Researchers investigated potential risk factors for the higher occurrence of asthma among individuals who have chronic rhinosinusitis with nasal polyps (CRSwNP).
Image of a patient with eczema
September 28th 2022

Real-world EoE Data Show More, Quicker Responses Among Concurrent Eczema, PFS

Jaime Rosenberg
Overall, 65% of patients went into remission throughout the observation period, with those with concurrent eczema and pollen food syndrome (PFS) having favorable responses.
Image of a nasal polyp
September 28th 2022

Pediatric ESS Effective, Safe to Treat Chronic Sinusitis With Nasal Polyps

Maggie L. Shaw
With a high recurrence rate following surgery to treat chronic sinusitis with nasal polyps, authors set out to investigate the effectiveness and safety of endoscopic sinus surgery (ESS) in a pediatric patient population.
biologic.
September 23rd 2022

Examining Biologic-Related Adverse Events in CRS With Nasal Polyps

Matthew Gavidia
Headaches, injection site reactions, and pharyngitis were the most common adverse events associated with the biologic therapies dupilumab, omalizumab, mepolizumab, and reslizumab in the treatment of chronic rhinosinusitis (CRS) with nasal polyps.
graphic of antibodies in blood
September 17th 2022

Antibody Level Linked to Milk Proteins, Consumption in Eosinophilic Esophagitis

Allison Inserro
It is already known that patients with eosinophilic esophagitis have higher levels of immunoglobulin G4, and this study examined the relationship to specific foods and aeroallergens.
Graphic showing figure on the outside of a group
September 15th 2022

Researchers Evaluate Racism as a Factor in Underestimation of Atopic Disease

Allison Inserro
Although allergic and atopic disease is well studied and researched overall, the researchers said there is a critical lack of knowledge about these conditions, including eosinophilic esophagitis, asthma, and atopic dermatitis, in diverse racial and ethnic groups.
Image of facial structure
September 14th 2022

Risk Factors for CRS Plus Asthma Differ Among Younger vs Older Patients

Maggie L. Shaw
Risk factors as predictors of asthma prevalence among a cohort of patients living with chronic rhinosinusitis (CRS), as they related to age, were evaluated by clinical investigators from the College of Medicine at Korea University.
Image of cost comparison
September 9th 2022

SCS Use May Predispose Patients Who Have CRSwNP to Worse Health Outcomes

Maggie L. Shaw
Using systemic corticosteroids (SCS) to treat chronic rhinosinusitis with nasal polyps (CRSwNP) has been linked to adverse outcomes among patients, prompting these study investigators to compare their health care resource utilization with that of patients who have CRSwNP but don’t use SCS.
Milk
September 8th 2022

OIT Can Continue Even if EoE Develops, Researchers Say

Allison Inserro
A recent study attempted to determine the prevalence of eosinophilic esophagitis (EoE) in a group of patients allergic to milk or egg and undergoing oral immunotherapy (OIT) to those foods, as well as describe its management and treatment pathway.
targets
September 2nd 2022

Success in Eosinophil-Targeted Treatments for EoE Remains Limited

Jaime Rosenberg
The researchers compiled data from studies of lirentelimab, mepolizumab, reslizumab, and benralizumab, highlighting the difficulties in finding an effective approach with eosinophil-targeted treatments for eosinophilic esophagitis (EoE).
Image of biomarker research
August 30th 2022

Bradykinin Level Displays Biomarker Benefit in Nasal Polyposis

Maggie L. Shaw
With evidence lacking on the role of inflammation in nasal polyposis (NP), this study investigated the role of 2 potential biomarkers in the nasal secretions of patients who have NP concomitant with aspirin-exacerbated respiratory disease.
graphic depicting science
August 27th 2022

Researchers Reexamine Budesonide for EoE in Meta-Analysis

AJMC Staff
In this study, researchers reaffirmed the safety and efficacy of using budesonide to treat eosinophilic esophagitis (EoE).
Picture of a nose
August 25th 2022

Combination Treatment Provides Short-term Endoscopic Relief in CRSwNP Subtype

Maggie L. Shaw
This study investigated combination treatment of antibiotics plus corticosteroids among persons with aspirin-exacerbated respiratory disease, a subtype of chronic rhinosinusitis with nasal polyposis (CRSwNP).
Prescription pad
August 18th 2022

Adherence to INC Treatment for Nasal Polyposis Remains Low

Maggie L. Shaw
Despite intranasal corticosteroid (INCs) being a treatment mainstay for chronic rhinosinusitis with nasal polyps, there are ongoing high rates of nonadherence, which can affect treatment efficacy, according to this study’s authors.
male patient with doctor
August 12th 2022

Researchers Advocate for Closer Monitoring of Patients With EoE

Allison Inserro
A study of adult patients with eosinophilic esophagitis in remission showed that those who were followed more closely in the maintenance phase of treatment had fewer strictures and had their disease activity found earlier.
map of Europe
August 8th 2022

Better Knowledge of EoE Results in Reduced Diagnostic Delay for European Patients

Alisha Lekh
European patients with eosinophilic esophagitis (EoE) had an improved diagnosis process and a faster diagnosis as new clinical practice guidelines were published over time, according to the results of a recent study.
Image of genetic testing
August 6th 2022

B7-H4 Identified as Potential Biomarker for CRSwNP in New Study

Maggie L. Shaw
This study investigated the potential for postoperative recurrence of chronic rhinosinusitis with nasal polyps (CRSwNP) as measured against B7-H4 expression.
Picture of glass of milk
August 5th 2022

Small Study Indicates Adults With EoE Can Tolerate Sterilized Milk

Allison Inserro
Cow's milk is the most common food trigger for eosinophilic esophagitis (EoE), a chronic inflammatory disease caused by type 2 inflammation.
Image of ongoing research
August 3rd 2022

Further Study Needed to Evaluate Olfaction Recovery in CRSwNP

Maggie L. Shaw
This new study evaluated outcomes following add-on dupilumab to treat severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP).
image of food stuck in throat
July 29th 2022

Esophageal Food Impaction in Adults May Portend EoE Diagnosis

Allison Inserro
The increase in esophageal food impaction can be traced to an increasing incidence and prevalence of eosinophilic esophagitis (EoE), researchers said.
Nose
July 28th 2022

Researchers Find Strong Overlap of Upper Airway Diseases

Laura Joszt, MA
There was also an association between outpatient visit burden and comorbidities and the number of inflammatory upper airway diseases.
<12345678
...
11>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo